Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cecconi

Showing results (1251-1260 of 1,385) with videos related to

Pageof 139
Sort By:
The Journal of Biological Chemistry|September 10, 2013
Structure, folding dynamics, and amyloidogenesis of D76N β2-microglobulin: roles of shear flow, hydrophobic surfaces, and α-crystallinP Patrizia Mangione, Gennaro Esposito, Annalisa Relini, et al.
Nature Cell Biology|December 2, 2014
AMBRA1 links autophagy to cell proliferation and tumorigenesis by promoting c-Myc dephosphorylation and degradationValentina Cianfanelli, Claudia Fuoco, Mar Lorente, et al.
Cell Death and Differentiation|January 30, 2010
A brain-specific isoform of mitochondrial apoptosis-inducing factor: AIF2E Hangen, D De Zio, M Bordi, et al.
Journal of Neuro-Oncology|August 13, 2025
Real-world experience with selumetinib in children with neurofibromatosis type 1: a multicentric retrospective studyClaudia Santoro, Mariachiara Servedio, Maria Cristina Diana, et al.
Communications Biology|July 19, 2025
Tissue-engineered neuromuscular organoidsBeatrice Auletta, Pietro Chiolerio, Giada Cecconi, et al.
Nature Communications|February 23, 2025
Increased ectodysplasin-A2-receptor EDA2R is a ubiquitous hallmark of aging and mediates parainflammatory responsesMaria Chiara Barbera, Luca Guarrera, Andrea David Re Cecconi, et al.
Intensive Care Medicine|May 19, 2018
Withholding or withdrawing of life-sustaining therapy in older adults (≥ 80 years) admitted to the intensive care unitBertrand Guidet, Hans Flaatten, Ariane Boumendil, et al.
Intensive Care Medicine|August 22, 2018
Correction to: Withholding or withdrawing of life-sustaining therapy in older adults (≥ 80 years) admitted to the intensive care unitBertrand Guidet, Hans Flaatten, Ariane Boumendil, et al.
Intensive Care Medicine|September 23, 2017
The impact of frailty on ICU and 30-day mortality and the level of care in very elderly patients (≥ 80 years)Hans Flaatten, Dylan W De Lange, Alessandro Morandi, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|March 9, 2021
Oligo metastatic renal cell carcinoma: stereotactic body radiation therapy, if, when and how?G Marvaso, G Corrao, O Oneta, et al.
Pageof 139

Showing results (1251-1260 of 1,385) with videos related to

Sort By:
Pageof 139
The Journal of Biological Chemistry|September 10, 2013
Structure, folding dynamics, and amyloidogenesis of D76N β2-microglobulin: roles of shear flow, hydrophobic surfaces, and α-crystallinP Patrizia Mangione, Gennaro Esposito, Annalisa Relini, et al.
Nature Cell Biology|December 2, 2014
AMBRA1 links autophagy to cell proliferation and tumorigenesis by promoting c-Myc dephosphorylation and degradationValentina Cianfanelli, Claudia Fuoco, Mar Lorente, et al.
Cell Death and Differentiation|January 30, 2010
A brain-specific isoform of mitochondrial apoptosis-inducing factor: AIF2E Hangen, D De Zio, M Bordi, et al.
Journal of Neuro-Oncology|August 13, 2025
Real-world experience with selumetinib in children with neurofibromatosis type 1: a multicentric retrospective studyClaudia Santoro, Mariachiara Servedio, Maria Cristina Diana, et al.
Communications Biology|July 19, 2025
Tissue-engineered neuromuscular organoidsBeatrice Auletta, Pietro Chiolerio, Giada Cecconi, et al.
Nature Communications|February 23, 2025
Increased ectodysplasin-A2-receptor EDA2R is a ubiquitous hallmark of aging and mediates parainflammatory responsesMaria Chiara Barbera, Luca Guarrera, Andrea David Re Cecconi, et al.
Intensive Care Medicine|May 19, 2018
Withholding or withdrawing of life-sustaining therapy in older adults (≥ 80 years) admitted to the intensive care unitBertrand Guidet, Hans Flaatten, Ariane Boumendil, et al.
Intensive Care Medicine|August 22, 2018
Correction to: Withholding or withdrawing of life-sustaining therapy in older adults (≥ 80 years) admitted to the intensive care unitBertrand Guidet, Hans Flaatten, Ariane Boumendil, et al.
Intensive Care Medicine|September 23, 2017
The impact of frailty on ICU and 30-day mortality and the level of care in very elderly patients (≥ 80 years)Hans Flaatten, Dylan W De Lange, Alessandro Morandi, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|March 9, 2021
Oligo metastatic renal cell carcinoma: stereotactic body radiation therapy, if, when and how?G Marvaso, G Corrao, O Oneta, et al.
Pageof 139